An Efficacy Study of 2',3'-Dideoxyinosine (ddI) (BMY-40900) Administered Orally Twice Daily to Zidovudine Intolerant Patients With AIDS or AIDS-Related Complex
Clinical trial NCT00000672 · COMPLETED
Trial details
- NCT number
- NCT00000672
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Primary completion
- 1993-02-01
- Enrollment
- 660
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.